Protecting American innovation from foreign threats is a national priority—particularly in strategic sectors like semiconductors, AI, and defense technologies. The United States has long relied on robust economic sanctions and export controls to protect national security and safeguard intellectual property (IP) from foreign adversaries. Despite these measures, a significant vulnerability persists: entities from sanctioned or embargoed nations can exploit a critical loophole to access the Patent Trial and Appeal Board (PTAB), an administrative body that plays a pivotal role in challenging the validity of U.S. patents.
Recent Posts
- Harrity & Harrity Seeks FT Patent Attorney / Agent in Electrical or Mechanical Technologies
- Understanding IP Matters: Celebrated MIT Engineer and Entrepreneur Develops Medical Devices to Treat Cancer and Other Diseases
- CAFC Finds IPR Petitioner Did Not Rely on AAPA as Basis for Obviousness Grounds in Affirming PTAB Invalidation
- Foreign Price Controls: A Risk to U.S. Medical Innovation and Patient Access
- Other Barks & Bites for Friday, July 11: EGC Affirms Annulment of Rubik’s Cube Marks; Sysco Trade Secret Case Dismissal Affirmed by Fourth Circuit; and EU Advocate General Finds Member States Can Impose Measures to Protect News Content on Meta Platforms